Search research articles
Contact Us
Filters
Showing results (181-190 of 205) with videos related to
Page
of 21
Sort By:
EMBO Molecular Medicine
|
December 16, 2015
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma
Alexander Scholz, Patrick N Harter, Sebastian Cremer, et al.
Acta Neuropathologica
|
October 18, 2021
Genetic and epigenetic characterization of posterior pituitary tumors
Simone Schmid, David A Solomon, Eilis Perez, et al.
Biorxiv : the Preprint Server for Biology
|
October 17, 2024
BRAF/MEK Inhibition Induces Cell State Transitions Boosting Immune Checkpoint Sensitivity in BRAFV600E -mutant Glioma
Yao Lulu Xing, Dena Panovska, Jong-Whi Park, et al.
Cell Reports. Medicine
|
June 12, 2025
BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAF<sup>V600E</sup>-mutant glioma
Yao Lulu Xing, Dena Panovska, Jong-Whi Park, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 17, 2025
Clinical potential of [<sup>18</sup>F]FET PET in patients with circumscribed astrocytic glioma
Jan-Michael Werner, Maximilian J Mair, Michael M Wollring, et al.
Acta Neuropathologica
|
April 25, 2026
Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas
Ramin Rahmanzade, Leonille Schweizer, Simone Schmid, et al.
Neuro-Oncology
|
November 1, 2020
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR
Philipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Neuro-Oncology
|
June 12, 2016
EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation
Eskil Eskilsson, Gro V Rosland, Krishna M Talasila, et al.
Acta Neuropathologica
|
August 16, 2019
MYCN amplification drives an aggressive form of spinal ependymoma
David R Ghasemi, Martin Sill, Konstantin Okonechnikov, et al.
Neuro-Oncology
|
May 6, 2023
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma
Michael C Burger, Marie-Therese Forster, Annette Romanski, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 205) with videos related to
Sort By:
Page
of 21
EMBO Molecular Medicine
|
December 16, 2015
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma
Alexander Scholz, Patrick N Harter, Sebastian Cremer, et al.
Acta Neuropathologica
|
October 18, 2021
Genetic and epigenetic characterization of posterior pituitary tumors
Simone Schmid, David A Solomon, Eilis Perez, et al.
Biorxiv : the Preprint Server for Biology
|
October 17, 2024
BRAF/MEK Inhibition Induces Cell State Transitions Boosting Immune Checkpoint Sensitivity in BRAFV600E -mutant Glioma
Yao Lulu Xing, Dena Panovska, Jong-Whi Park, et al.
Cell Reports. Medicine
|
June 12, 2025
BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAF<sup>V600E</sup>-mutant glioma
Yao Lulu Xing, Dena Panovska, Jong-Whi Park, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 17, 2025
Clinical potential of [<sup>18</sup>F]FET PET in patients with circumscribed astrocytic glioma
Jan-Michael Werner, Maximilian J Mair, Michael M Wollring, et al.
Acta Neuropathologica
|
April 25, 2026
Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas
Ramin Rahmanzade, Leonille Schweizer, Simone Schmid, et al.
Neuro-Oncology
|
November 1, 2020
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR
Philipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Neuro-Oncology
|
June 12, 2016
EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation
Eskil Eskilsson, Gro V Rosland, Krishna M Talasila, et al.
Acta Neuropathologica
|
August 16, 2019
MYCN amplification drives an aggressive form of spinal ependymoma
David R Ghasemi, Martin Sill, Konstantin Okonechnikov, et al.
Neuro-Oncology
|
May 6, 2023
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma
Michael C Burger, Marie-Therese Forster, Annette Romanski, et al.
Page
of 21